The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike injections, this method offers a simpler way to provide GLP-1 drugs. These https://barbaraioxp544730.aioblogs.com/93674553/glp-1-patches-a-innovative-approach-to-diabetes-control